235 related articles for article (PubMed ID: 20942728)
21. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
[TBL] [Abstract][Full Text] [Related]
22. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
[TBL] [Abstract][Full Text] [Related]
23. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
24. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
25. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
[TBL] [Abstract][Full Text] [Related]
26. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.
Jeh SK; Kim SH; Kim HS; Kang BJ; Jeong SH; Yim HW; Song BJ
J Magn Reson Imaging; 2011 Jan; 33(1):102-9. PubMed ID: 21182127
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
28. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
Schedel H; Oellinger H; Kohlschein P; Siewert C; Hadijuana J; Blohmer JU; Kissner T; Felix R
Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495
[TBL] [Abstract][Full Text] [Related]
29. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
30. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
[TBL] [Abstract][Full Text] [Related]
31. [Application of dynamic contrast enhancement MRI and post-processing technique for diagnosis of breast cancer].
Peng KQ; Huang ZL; Xie CM; Chen L; Ouyang Y; Zheng QS; Zhang Y; He HQ; Wu PH
Ai Zheng; 2009 May; 28(5):549-54. PubMed ID: 19624888
[TBL] [Abstract][Full Text] [Related]
32. Robust segmentation of mass-lesions in contrast-enhanced dynamic breast MR images.
Meinel LA; Buelow T; Huo D; Shimauchi A; Kose U; Buurman J; Newstead G
J Magn Reson Imaging; 2010 Jul; 32(1):110-9. PubMed ID: 20578017
[TBL] [Abstract][Full Text] [Related]
33. Extension of breast cancer: comparison of CT and MRI.
Nakahara H; Namba K; Wakamatsu H; Watanabe R; Furusawa H; Shirouzu M; Matsu T; Tanaka C; Akiyama F; Ifuku H; Nakahara M; Tamura S
Radiat Med; 2002; 20(1):17-23. PubMed ID: 12002599
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.
Costantini M; Belli P; Rinaldi P; Bufi E; Giardina G; Franceschini G; Petrone G; Bonomo L
Clin Radiol; 2010 Dec; 65(12):1005-12. PubMed ID: 21070905
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings.
Mariano MN; van den Bosch MA; Daniel BL; Nowels KW; Birdwell RL; Fong KJ; Desmond PS; Plevritis S; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
J Magn Reson Imaging; 2005 Oct; 22(4):520-6. PubMed ID: 16142701
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced dynamic MR imaging parameters and histological types of invasive ductal carcinoma of breast.
Takeda Y; Yoshikawa K
Biomed Pharmacother; 2005 Apr; 59(3):115-21. PubMed ID: 15795104
[TBL] [Abstract][Full Text] [Related]
37. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma.
Schouten van der Velden AP; Boetes C; Bult P; Wobbes T
Am J Surg; 2006 Aug; 192(2):172-8. PubMed ID: 16860625
[TBL] [Abstract][Full Text] [Related]
38. Comment on ADC reductions in postcontrast breast tumors.
Ramadan S; Mulkern RV
J Magn Reson Imaging; 2010 Jan; 31(1):262; author reply 263-4. PubMed ID: 20027600
[No Abstract] [Full Text] [Related]
39. A case of ductal carcinoma in situ of the breast.
Yoshida M; Kinoshita T
Jpn J Clin Oncol; 2009 Feb; 39(2):132. PubMed ID: 19155284
[No Abstract] [Full Text] [Related]
40. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
